UC San Francisco has been awarded $67.5 million to develop new antiviral therapies. Other news stories are unrelated to this award, discussing topics such as a utility company's earnings and a daily business report from several years ago. The award to UC San Francisco appears to be the only relevant information available about the development of new antiviral therapies.